NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Manipal Health Enterprises Ltd Files Draft Papers for Rs 8,000 Crore IPO

Key Highlights

  • Manipal Health Enterprises Ltd has filed draft papers with the Securities and Exchange Board of India (SEBI) to raise funds via an initial public offering (IPO).
  • The IPO comprises a fresh issue of Rs 8,000 crore and an offer for sale (OFS) of up to 43.23 million shares by promoters and existing shareholders.

Offer for Sale

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

  • Imperius Healthcare Investments plans to sell 21.62 million shares.
  • Manipal Education and Medical Group plans to sell 13.58 million shares.
  • TPG SG Magazine plans to sell 4.66 million shares.
  • Seventy Second Investment plans to sell 1.58 million shares, among others.

Fresh Issue

  • The proceeds from the fresh issue will be used primarily for:
    • Repayment of debt worth Rs 5,378 crore.
    • Acquisition of a minority stake worth Rs 574 crore in its step-down subsidiary, Sahyadri Hospitals.

Debt Repayment

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

  • As of January 31, 2026, the company had total consolidated outstanding borrowings of Rs 10,612.79 crore.

Book-Running Lead Managers

  • Kotak Mahindra Capital, Axis Capital, Goldman Sachs India, Jefferies India, JP Morgan India, UBS Securities India, and DBS Bank India are the book-running lead managers to the issue.

Company Overview

  • Manipal Health operates a pan-India network of multi-specialty hospitals offering a comprehensive range of healthcare services.
  • As of September 30, 2025, the company operated 38 hospitals (48 on a pro forma basis) with 10,761 licensed beds (12,367 on a pro forma basis) across 14 states and union territories.

Financial Performance

  • For FY25, the company reported revenue from operations of Rs 9,263.56 crore on a pro forma basis, compared to Rs 6,171.63 crore in the previous year.
  • Net profit stood at Rs 534.7 crore, compared to Rs 533.2 crore.

Investor Takeaway

Investors should be aware of the upcoming IPO and potential impact on the healthcare sector.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.